Stephens & Co. Reiterates Equal-Weight on Insight Molecular, Maintains $4 Price Target
Stephens & Co. analyst Mason Carrico reiterates Insight Molecular (NASDAQ:IMDX) with a Equal-Weight and maintains $4 price target.
Follow the latest Insight Molecular Diagnostics Inc. (IMDX) news and market headlines alongside the live IMDX price. Stay informed on what's moving IMDX.
Stephens & Co. analyst Mason Carrico reiterates Insight Molecular (NASDAQ:IMDX) with a Equal-Weight and maintains $4 price target.
Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 21.2% to $0.5 during Wednesday's pre-market session. The company's market cap stands at $7.6 million. As per the press release, Q3 earnings came
Gainers Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to IMDX, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.